B

Boltz

Boltz is a startup that builds AI models for designing drug molecules. It targets pharmaceutical companies and has seen significant growth in usage of its models, which are deployed at major firms like Pfizer and GSK. The company charges for model use based on molecular tokens, allowing scientists to retain ownership of their creations.

Total raised
Undisclosed
tracked to date
Latest round
Series A
Nov 18, 2026
Known investors
8
led by Bessemer Venture Partners
Press coverage
6
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund AI startups in United Kingdom.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 UK Funding Report

Read the Q4 2026 UK report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-uk-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 UK Funding Report</a>

Funding history

  1. 1
    $110 millionSeries ANov 18, 2026

    Led by Bessemer Venture Partners

    Announcement ↗

Founder

N
null

Investors in Boltz

Backers from this company's tracked funding rounds.

Boltz in the news

Coverage of this company's funding, tracked by Datapile.

More AI companies

Recently funded startups in the same category.

Related on Datapile